Many Drinkers Cut Back After Starting Obesity Meds, Study Finds In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug Nov 26, 2024
CGM Uptake Very Low for Vulnerable Diabetes Populations But how to achieve equitable use remains "complicated," says expert Nov 22, 2024
GLP-1 Use Prior to Surgery: Analyzing the Updated Guidance Balancing aspiration risk with the consequences of medication discontinuation Nov 20, 2024
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy Most are eligible for weight management indication Nov 18, 2024
Tirzepatide Officially Puts GLP-1 Meds on the Map for Heart Failure Benefit SUMMIT trial able to show clinical benefit beyond quality-of-life improvement Nov 16, 2024
Multiple Chronic Conditions and Death; Diabetes Treatment for Gout Also in TTHealthWatch: frailty as a predictor of dementia Nov 16, 2024 podcast
GLP-1 Drugs Could Help People With Alcohol Use Disorder Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations Nov 13, 2024
Who Needs a Defibrillator After MI? FDA Recs on Inferior Vena Cava Filters Also in TTHealthWatch: early sugar exposure, hypertension, and diabetes Nov 09, 2024 podcast
Nurse's Death Tied to GLP-1 Drug; Research Monkey Jailbreak; Congressman Has Cancer Health news and commentary gathered by 鶹ý staff Nov 08, 2024
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist Nov 07, 2024
Early-Life Sugar Restriction Reduced Diabetes, Hypertension Risk Diagnoses were also delayed the longer sugar was restricted Nov 06, 2024
Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy? Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s Nov 05, 2024
ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents Oct 30, 2024
No Kidney Benefit With Finerenone in Heart Failure Patients Anti-mineralocorticoid agent reduced albuminuria, but not eGFR-based kidney outcome Oct 28, 2024
Metformin and Congenital Abnormalities; Deprescribing in Patients With Dementia Also in TTHealthWatch: best medications for opioid use disorder Oct 26, 2024 podcast
Ozempic Linked With Lower Risk of Alzheimer's Diagnosis Large observational study suggests further research is warranted Oct 24, 2024
Scripts for GLP-1, SGLT2 Drugs on the Rise in Type 1 Diabetes Patients Findings leave researcher "concerned" Oct 23, 2024
No X-Ray Proof of Rare Surgical Complication Tied to GLP-1 Agonists Conundrum of holding meds continues following conflicting reports of aspiration events Oct 22, 2024
Serious Battery Issue Prompts Medtronic Insulin Pump Recall Problem linked to 170 reports of hyperglycemia and 11 ketoacidosis cases Oct 18, 2024
Type 2 Diabetes Diagnoses Emerge in Teens Months After COVID Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections Oct 14, 2024
What Skin Says About Health Knowing what to look for can mean the difference between life and death Oct 03, 2024
Food Retention Risk Low for GLP-1 Users When Endoscopy Is Combined With Colonoscopy Bowel preparation protocols appeared protective in small study Oct 01, 2024
Happy People, Happy Hearts? Ultra-Processed Foods and Diabetes Risk Also in TTHealthWatch: AACR report on cancer Sep 28, 2024 podcast
GLP-1 Agent May Hold Opioid Use Disorder Benefit Researchers highlight semaglutide's potential value for preventing overdoses Sep 26, 2024
FTC Sues Top Pharmacy Benefit Managers Over Insulin Prices The three companies process about 80% of prescriptions in the U.S. Sep 20, 2024
Coffee and Heart, Metabolic Risks; What Drives Doctors Away; Ozempic for $100? Health news and commentary gathered by 鶹ý staff Sep 18, 2024
Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening More noteworthy research from the EASD 2024 meeting Sep 13, 2024
8-Hour Eating Window Improved Glycemic Control, Small Study Shows Three-day intervention boosted time spent in normal glucose range Sep 13, 2024
Direct-to-Consumer Drugs: Big Pharma's Digital Health Play Regulators will need to closely watch this new frontier Sep 13, 2024
Weekly Insulin Efsitora Noninferior to Daily Degludec in Type 1, Type 2 Diabetes But higher severe hypoglycemia risk with efsitora in type 1 diabetes likely precludes its use Sep 10, 2024
New Studies Fuel Debate Over GLP-1 Drugs and Suicide Risk No link found in nationwide data from Sweden and Denmark and in analysis of STEP trials Sep 03, 2024
FDA Clears First Automated Insulin-Delivery Tech for Type 2 Diabetes SmartAdjust technology is used in Insulet's Omnipod 5 Automated Insulin Delivery System Aug 27, 2024
Matthew Perry's Doc Reopens Clinic; Trump's Medical Records; Drug Cuts Diabetes Risk Health news and commentary gathered by 鶹ý staff Aug 21, 2024
Here's How Compounders Make Popular Weight-Loss Drugs From sourcing API to getting the final formulation just right Aug 19, 2024
Is Medicare's Negotiated Drug Price List Worth Celebrating? Depends on Whom You Ask. Reactions from physician and consumer groups were positive, but drugmakers begged to differ Aug 16, 2024
GLP-1 Agonists for Diabetes Tied to Lower Hyperkalemia Rates Class was compared with DPP4-inhibitors Aug 12, 2024
Dementia Risk Dropped With Anti-Inflammatory Diet for Certain Patients Brain markers of degeneration, injury were better, too Aug 12, 2024
